---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-018824"
form_type: "8-K"
ticker: null
cik: "0001538217"
company_name: "SRAX, Inc."
filed_at: "2024-05-13T23:59:59+00:00"
generated_at: "2026-06-02T02:17:23.975659+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# SRAX signs definitive merger agreement with DNA Holdings; DNA shareholders to get ~75.5% of SRAX common stock

## Summary
- SRAX will issue 1,000 shares of Series C Preferred Stock convertible into ~75.5% of SRAX common stock upon closing.
- DNA currently owns ~35% of SRAX; the combined company will be renamed DNA Holdings Venture Inc.
- Closing conditions include DNA advancing at least $500,000 to SRAX and SRAX becoming current on SEC filings.
- Christopher Miglino will remain CEO of the combined entity; the boards of both companies unanimously approved the deal.

## SEC filing metadata
- accession: 0001493152-24-018824
- form_type: 8-K
- cik: 0001538217
- company_name: SRAX, Inc.
- filed_at: 2024-05-13T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1538217/000149315224018824/0001493152-24-018824-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1538217/000149315224018824/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-018824
- JSON: https://secwatch.observer/filing/0001493152-24-018824.json
- Plain text: https://secwatch.observer/filing/0001493152-24-018824.txt

## Key facts
- Material Agreements
  SRAX, Inc. entered into Agreement and Plan of Merger with DNA Holdings Venture, Inc. (effective 2024-05-07).
  - Action: entry
  - Agreement: merger
  - Counterparty: DNA Holdings Venture, Inc.
  - Effective: 2024-05-07
  source text: On May 7, 2024, SRAX, Inc., a Delaware corporation (“SRAX”), entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) with DNA Holdings Venture, Inc., a Puerto Rico corporation (“DNA”), and DNA Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of SRAX (“Merger Sub”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1538217/000149315224018824/0001493152-24-018824-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.